Related Experiment Video
Updated: Aug 13, 2026
08:56
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
[Bile secretion in the liver caused by verapamil]
S V Tukaev1, S P Vesel'skiĭ, E N Reshetnik
1Kiev National University, 64 Volodimirska St., 01033 Kiev, Ukraine.
Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova
|December 31, 2002
Summary
Verapamil
Area of Science:
- Hepatology and Pharmacology
- Investigating drug effects on liver function
Background:
- Liver secretory function is crucial for bile production.
- Bile acids and lipids are key components of bile.
- Verapamil is a known calcium channel blocker.
Purpose of the Study:
- To investigate the impact of verapamil on liver secretory function in rats.
- To determine if verapamil's effects vary based on initial bile secretion levels.
Main Methods:
- Administered verapamil to rats with varying initial bile secretion rates.
- Monitored bile flow, bile acid, and lipid secretion.
- Analyzed changes in conjugated and unconjugated bile salts, phospholipids, and cholesterol.
Main Results:
- In rats with low initial bile secretion, verapamil increased bile flow and taurine-conjugated bile salts, while decreasing glycine-conjugated and unconjugated bile salts.
- In rats with high initial bile secretion, verapamil decreased bile flow, unconjugated bile salts, taurine/glycine-conjugated bile salts, phospholipids, and cholesterol.
- Verapamil demonstrated dose-dependent effects on biliary secretion.
Conclusions:
- Verapamil influences bile secretion regulation in a manner dependent on the initial secretory level.
- The drug's effects suggest a role in modulating bile acid and lipid transport.
- Further research is warranted to elucidate the precise mechanisms of verapamil's action on hepatic secretion.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:19Bile
Bile is a crucial bodily fluid, characterized by its yellow-green color and alkaline nature. Produced in the liver, it is transported through the common hepatic duct into either the cystic duct, leading to the gallbladder, or directly into the common bile duct. The flow of bile is regulated by the sphincter of Oddi located at the entrance of the duodenum. When this sphincter is closed, bile is redirected to the gallbladder for storage and concentration.
Bile is released when dietary fats enter...
Bile is released when dietary fats enter...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:17Hepatic Drug Excretion: Enterohepatic Cycling
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
01:16Hepatic Drug Excretion: Influencing Factors
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
01:20Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...